登录

Osmind宣布与美国精神病学会合作,推进高质量的精神病护理并加快研究

Osmind Announces Collaboration with the American Psychiatric Association to Advance Quality Psychiatric Care and Accelerate Research

businesswire | 2024-05-02 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


SAN FRANCISCO--(BUSINESS WIRE)--Today, Osmind, the leading psychiatric treatment and research platform, announced an innovative collaboration with the American Psychiatric Association (APA) to improve the adoption of measurement-based care (MBC) and precision treatment in psychiatry. This collaboration between Osmind and APA’s PsychPRO registry intends to broaden access to personalized care, improve patient outcomes, generate robust real-world evidence (RWE) and accelerate psychiatry’s evolution to precision medicine.

旧金山-(商业新闻)-今天,领先的精神病治疗和研究平台Osmind宣布与美国精神病学协会(APA)进行创新合作,以改进基于测量的护理(MBC)和精神病学精确治疗的采用。Osmind和APA的PsychPRO注册中心之间的合作旨在扩大个性化护理的范围,改善患者的预后,产生强大的现实世界证据(RWE),并加速精神病学向精准医学的发展。

PsychPRO registry is a clinical data registry that enables the collection and analysis of clinical data to advance quality improvement efforts and accelerate research for the psychiatric community..

PsychPRO registry是一个临床数据注册中心,可以收集和分析临床数据,以推进质量改进工作,并加速精神病社区的研究。。

'At Osmind, we emphasize the importance of clinicians participating in evidence-generating medicine to help shape the future of mental health care, especially as the psychiatric field begins to embrace new treatments and precision psychiatry,” said Carlene MacMillan, MD, Chief Medical Officer of Osmind.

Osmind首席医疗官Carlene MacMillan医学博士说:“在Osmind,我们强调临床医生参与循证医学的重要性,以帮助塑造精神卫生保健的未来,特别是在精神病学领域开始接受新疗法和精确精神病学的情况下。”。

“Clinicians in private practice juggle many competing demands so it is crucial we make participation both easy and worthwhile to them.'.

“私人诊所的临床医生兼顾了许多相互竞争的需求,因此至关重要的是,我们让他们的参与既容易又有价值。”。

Osmind is integrating a number of APA’s diagnostic and outcomes measures of interest, including the DSM-5-TR Self-Rated Level 1 Cross-Cutting Symptom Measure developed by APA researchers, into its electronic health record (EHR) software. The first measure of interest is now available to Osmind clinicians and is part of a library of 40+ measures already in its EHR.

Osmind正在将APA的许多感兴趣的诊断和结果指标整合到其电子健康记录(EHR)软件中,包括由APA研究人员开发的DSM-5-TR自评1级交叉症状指标。Osmind临床医生现在可以使用第一个感兴趣的指标,并且是其EHR中已有的40多个指标库的一部分。

Osmind will also help promote adoption of the new APA measures through education, automation, and engagement directly in the EHR at the point of care..

Osmind还将通过教育、自动化和在护理点直接参与EHR来帮助推动采用新的APA措施。。

Osmind and APA will additionally explore a seamless integration between the Osmind EHR and PsychPRO so that clinicians using the Osmind EHR can participate effortlessly in the PsychPRO registry. PsychPRO participation supports the standardization of high-quality care and benefits clinicians. Key benefits for clinicians include the ability to better understand how the care they deliver impacts their patient outcomes, and how their patient outcomes compare to their peers across the country in all types of care settings..

Osmind和APA还将探索Osmind EHR和PsychPRO之间的无缝集成,以便使用Osmind EHR的临床医生可以毫不费力地参与PsychPRO注册表。PsychPRO的参与支持高质量护理的标准化,并使临床医生受益。临床医生的主要好处包括能够更好地了解他们提供的护理如何影响他们的患者结果,以及他们的患者结果如何与全国各地的同行在所有类型的护理环境中进行比较。。

Following the successful prospective data capture phase, the collaboration plans to also consider joint research initiatives. Data and feedback collected by Osmind and PsychPRO would be used to analyze outcomes, validate the effectiveness of the measures, enhance clinical practices and guide ongoing research in precision psychiatry..

在成功的前瞻性数据采集阶段之后,合作计划还将考虑联合研究计划。Osmind和PsychPRO收集的数据和反馈将用于分析结果,验证措施的有效性,加强临床实践并指导正在进行的精确精神病学研究。。

'PsychPRO is the tool healthcare organizations need to guide their efforts to deliver quality mental health care and improve patient outcomes,' said Nitin Gogtay, MD, APA Chief of Research and Deputy Medical Director. 'Our collaboration with Osmind will allow us to strengthen PsychPRO today, and long-term offers promise to broaden the scope of our impact on psychiatry and on the patients we serve.'.

“PsychPRO是医疗保健组织需要的工具,可以指导他们努力提供高质量的心理健康护理,改善患者的预后,”APA研究主管兼副医学主任尼廷·戈特伊(NitinGogtay)医学博士说我们与Osmind的合作将使我们今天能够加强PsychPRO,并且长期的承诺将扩大我们对精神病学和我们服务的患者的影响范围。”。

Osmind’s modern and easy-to-use EHR serves independent psychiatric practices across the country, helping them treat their patients with the highest quality care. Through this collaboration, Osmind is enabling independent practices to contribute to the evolution of the field and elevate their own evidence-based practices..

Osmind的现代且易于使用的EHR服务于全国各地的独立精神病学实践,帮助他们以最高质量的护理来治疗患者。通过这种合作,Osmind使独立实践能够为该领域的发展做出贡献,并提高他们自己的循证实践。。

About Osmind

关于Osmind

Osmind is a San Francisco–based public benefit corporation led by scientists, technologists, and psychiatrists to advance new evidence-generating medicine that helps people living with moderate to severe mental health conditions. For more information, please visit www.osmind.org.

Osmind是一家总部位于旧金山的公益性公司,由科学家、技术专家和精神病医生领导,旨在推进新的循证医学,帮助患有中度至重度心理健康状况的人。有关更多信息,请访问www.osmind.org。

About the American Psychiatric Association

关于美国精神病学协会

The American Psychiatric Association, founded in 1844, is the oldest medical association in the country. The APA is also the largest psychiatric association in the world with more than 38,900 physician members specializing in the diagnosis, treatment, prevention, and research of mental illnesses. APA’s vision is to ensure access to quality psychiatric diagnosis and treatment.

美国精神病学协会成立于1844年,是美国历史最悠久的医学协会。APA也是世界上最大的精神病学协会,拥有38900多名医师成员,专门从事精神疾病的诊断、治疗、预防和研究。APA的愿景是确保获得高质量的精神病诊断和治疗。

For more information, please visit www.psychiatry.org..

欲了解更多信息,请访问www.psychiatry.org。。

推荐阅读

Osmind重塑精神病临床医生的保险报销,扩大患者获得心理健康护理的机会

businesswire 2023-10-24 19:30

全球投资紧缩,医保支付平台Walnut成唯一融资过亿企业【2022年5月全球数字健康投融资月报】

动脉网APP 2022-06-08 10:43

Parallel Bio推出利用类器官加速药物发现的新型临床试验方法

PHARMA FOCUS ASIA 2024-05-17 17:55

businesswire

6555篇

最近内容 查看更多

Drug Farm宣布美国食品药品监督管理局批准IND,使ROSAH综合征患者能够启动ALPK1选择性激酶抑制剂DF-003的1b期启动

6 小时后

Cleveland Bakers and Teamsters健康与福利基金与Curio Digital Therapeutics合作,为会员提供革命性的孕产妇心理健康支持

7 小时前

里程碑式研究表明,CareDx的HeartCare在识别排斥反应方面优于单独的dd-cfDNA,患者在更少的活检中获得了良好的结果

8 小时前

相关公司查看更多

Osmind

软件解决方案提供商

立即沟通

产业链接查看更多

所属赛道

专科医院与诊所
医疗信息化
近30天,融资13起
在国民爱牙意识增强、口腔诊疗需求扩大、国民收入快速增长、民营口腔医疗机构持续发力等因素的驱动下,预计未来口腔医疗服务市场将持续快速扩张,有望于2026年突破3千亿元,达到约3182亿元。预计2022年到2026年的复合增长率将达到15.6%。
电子病历
动脉橙产业智库梳理了:电子病历相关公司、关联事件300+;近10年投融资总额超44亿元人民币;产业图谱、招标采购、TOP公司作战地图等分析维度持续更新。因国内外关于电子病历定义存在分歧,故动脉橙产业智库重点梳理国内电子病历相关公司。